Member-centered cancer care In Georgia

Similar documents
How health plans can improve cancer care: from utilization management to delivery reform

Oncology Management at HAP. John Calabria, DO, Medical Director

The New Role of Cancer Patient Engagement in Value Based Models

Innovation in Physician Payment and Organization for Cancer Care. Jennifer Malin, MD, PhD Medical Director, Oncology

2014 Medicare (and Private Insurance) Payment Reform for Oncology. Ensuring the Delivery of Quality & Value-Based Cancer Care

The Oncology ACO The Forum for Re-engineering the Cancer Care Delivery Process and for Harnessing the Cancer Spend October 2013

To Bundle or Not to Bundle?

Patient-Centered Oncology Payment: Payment Reform to Support Higher Quality, More Affordable Cancer Care (PCOP)

WHAT DOES IT TAKE TO SCALE HOME-BASED PALLIATIVE CARE?

Clinical Pathways in the Oncology Care Model

ONCOLOGY MEDICAL HOME ACCREDITATION

ACO Congress Conference Pre Session Clinical Performance Measurement

BETTER WAYS TO PAY FOR CANCER CARE Creating Win-Win-Win Approaches for Oncologists, Cancer Patients, and Payers

The Changing Landscape of Palliative Care

9/18/2018. Reforming Care Beyond Healthcare: Opportunities & Challenges for True Palliative Care. Perspectives

WELLPOINT RESPONDS TO ANCO s COMMENTS

Key Trends for Ambulatory Surgery Centers in 2018

7-year Journey reaps Decline in Medical Spend. Who is Goodwill?

Protecting the Future of Oncology Care A Community Conversation. Presentations by:

Dauna Howerton, Ph.D. Behavioral Health Services Division October 8, New Mexico Human Services Department

How to Integrate Peer Support & Navigation into Care Delivery

THE GROWTH OF SPECIALTY PHARMACY

DOUBLE YOUR AMBULATORY PLATFORM

FAMILY & CHILDREN S SERVICES STRATEGIC PLAN

PA Optometric Association Annual Congress

Walgreens. Specialty Pharmacy Marketing Video

Session 304: How to Integrate Palliative Care Into Your Community-based Home Health and Hospice Programs

Across The Chasm: The Transition From Volume To Value

Cognizanti. You Don t Join Us; We Join You. Insurance/Health & Wellness VOLUME

How is quality perceived and measured when cancer is a chronic condition? Jennifer Malin, MD, PhD, Staff Vice President, Clinical Strategy, Anthem

Foundations in Community-Based Palliative Care Essential Elements for Success

Leveraging Your Cancer Registry: A Strategy for Survey Success

Note: This is an authorized excerpt from 2016 Healthcare Benchmarks: Population Health Management. To download the entire report, go to

The Challenge. Bill Frist, M.D.!

Successes in Regional Collaboration to Achieve the Triple Aim Oregon. Pay for Performance Summit San Francisco March 24, 2014

Home-Based Primary Care (HBPC): Local Efforts Have National Impact. Eric De Jonge, M.D. Director of Geriatrics, MWHC. No Financial Disclosures

THE COST DRIVERS OF CANCER CARE

Partnering with Doctors through Co-Management

Session 127 PD - Palliative Care: Improving Quality While Lowering Cost. Moderator: Allison Silvers

South West Regional Cancer Program. Cancer Plan

Trends in Oncology: Preparing for Seismic Change. ASCO s Clinical Affairs Department

Driving to Value: Transitioning from Fee for Service. Walter LeStrange

From Channeling to GRACE: Approaching Reduction in Readmissions and Adverse Drug Events

Maximize the value of your diabetes population management program with advanced analytics PLAYBOOK

PCP and Specialist Communication and Collaboration. May 4, 2011

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE

Engaging patients and providers with the right information, at the right time, to do the right thing

The changing demand of cancer services in Hong Kong can be summarized as follows:

Value-Driven Population Health Strategies: Designing Models for Different Populations

Innovator Case Studies: Oncology Networks

62 accc-cancer.org January February 2016 OI

Watson Summit Prague 2017

Billing and Payment Models for Palliative Care

Whither the Patient in the Age of Big Data?: High Tech, High Touch or Both. J. Russell Hoverman, MD, PhD Vice President, Quality Programs

London Regional Cancer Program

Anthem s Cancer Care Quality Program: Pathways to Improve Care and Reduce Costs

Population health: Going beyond primary care, making it work in a complex health system. Mary Brainerd, HealthPartners President and CEO

Practical Predictive Analytics. John Cuddeback, MD, PhD AMA IPPS November 11, 2016

Are we doing good yet? Assessing value in Oncology

Atrius Health Pioneer ACO: Structure, Activities and Results

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

SUPPORTING EMPLOYEES WITH CANCER: THE CANCER CARE HUDDLE. March 26, 2018

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

Real World Patients: The Intersection of Real World Evidence and Episode of Care Analytics

Using Analytics for Value-Based Care

2017 Davies Award. Kressly Pediatrics Case Studies SUSAN J. KRESSLY, MD, FAAP

Making the Most of Your Cancer Registry

Imaging Performance Partnership. A Data Driven Approach to Your Imaging Program Strategy

Population Health Management Design: Optimizing the Outcomes for Special Populations 21th Annual ASHP Conference for Pharmacy Leaders

September 22, National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC Prescription Opioid Epidemic

SmartIX EMPI Taking It to the Next Level

Coding for Care: Using Data Analytics for Risk Adjustment. March 2, 2016 Clive Fields, MD, President, Village Family Practice

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

Measuring and Improving Quality in Accountable Care Organizations

Patient-Centered Medical Home

Sanofi Press Breakfast on Behavioral Science. Friday 22 September 2017

Readmission Strategies: Palliative Care as a Piece of the Puzzle

Social Determinants of Health

Livongo Drives 1.4x ROI in Year 1 for Dean Foods

Big Data & Predictive Analytics Case Studies: Applying data science to human data Big-Data.AI Summit

AdvaMed Medtech Value Assessment Framework in Practice

The future of healthcare is data.

Georgia Cancer Quality Information Exchange

REVIEW AND FREQUENTLY ASKED QUESTIONS (FAQ) 8/5/2015. Outline. Navigating the DSMT Reimbursement Maze in Todays Changing Environment

Realigning Reimbursement Policies for Quality and Value in Cancer Care

A Closer Look at Radiology s Role in Corporate Healthcare. Mark D. Jensen, CEO, Charlotte Radiology

Driving Outcomes By Scaling Population Health Management

The MGH Journey. Shaping the Future of an Entire Region

Using Pay-for-Performance to Improve COPD Care MHC64474 SV64474

Message from Leadership

Insight ONCOLOGY. Drug Class. Background, new developments, key strategies INTRODUCTION. Incidence of cancer types per year

Palliative Care in the Continuum of Oncologic Management

Personalized Medicine Disruptive Technology? David Logan Senior Vice President, Commercial Genomic Health Inc

Innovative Risk and Quality Solutions for Value-Based Care. Company Overview

ASO core offerings. Self-funded groups, sized 100+

From Data to Optimized Healthcare Outcomes: Using Prescriptive Analytics to Maximize Patient Access, Costs and Quality of Care

Community Health Improvement Plan

Implement Spine to Drive Higher Performance of Your Surgery Center. Surgery Center Industry Challenges. Recognize the Challenges

The Oncology Care Model: What Is It? Implications for IOD? Ronald Barkley, MS, JD Alti Rahman, MHA, MBA October 28, 2016

Gavi s private sector engagement approach

Transcription:

Quality health plans & benefits Healthier living Financial well-being Intelligent solutions Member-centered cancer care In Georgia Ira Klein, MD, MBA, FACP GASCO Annual Meeting September 5, 2015 > One half million Aetna medical benefit members in Georgia #12 nationally for Aetna in office based oncology cost spend

Aetna Values & Oncology Solutions Mission Statement Aetna Oncology Solutions Mission Statement: We give our members access to high-value, personalized cancer care models. We collaborate with oncology teams that deliver best-in-class care by using evidence-based medical guidelines, clinical decision support tools and services that improve the patient s experience, increase effectiveness of care and lower costs. Our value-based approach, powered by data analytics and transparency of policy and payment, allows us to move from a fee-for-service platform to a value-driven system that rewards Oncology practices for quality care throughout the patient s care journey.

The principles of our strategy are simple Drive efficient use of evidence-based medicine Leverage technology platform s that provide content and workflows Integrate those platforms into the Aetna and provider systems Simplify the administrative processes for providers Improve the care experience for the members with cancer Avoid waste and misuse of medical services Align provider incentives, which includes transparency & reporting (e.g., Oncology Medical Home), Improve network configuration (narrow, tiered) to drive improved cost and quality Implement better decision support strategies Provide improved patient support in active treatment and care transitions Leverage and integrate the many current (and future) medical and pharmacy and HIT cancer-care initiatives Create a seamless, end to end clinical treatment experience for Aetna members and providers 3

We assess overall value in oncology care based on total cost of care and care experience evidence V = Q C Guideline Based Therapies Targeted Impact Low Toxicities Improved Survival Improved QOL Best Supportive Care Avoidance Hospital Days Avoidance ED Visits Site of Service Costs Medically Unnecessary Care at EOL 4

We re here to help you manage all the forces at play / key cost drivers 5

Aetna collaboratively supports the oncology practice world s needs Aetna supports moving up the pyramid Transformative Population-Based Mgmt, Steerage Preferred Network Status Nirvana Detailed QI Reporting, Benchmarks Oncology Medical Home Contract Measurable clinical outcomes Additional Tools (Pt. Satisfaction Reporting, etc..) Improved Pre-cert process Better patient service aspects of practice Basic Resource Use Reporting Clinical Decision Support Contracts Improving office operational efficiency, time and FTE s Enhanced Generic Fees FFS contract Par Network Status Managing to stay in business and the ability to keep revenues > expenses Foundational

Oncology and where we ve been with pilots, 2010-2013: P4V programs, contracted on case rate basis, only managing new Dx (incidence) and new chemo starts Cardinal/P4 Pilot in MD, DC, N. VA had net savings of $393,599 included in reduced ER visits, in-patient hospital stays and spend on certain drugs Innovent Pilot in TX (commercial pop. only) demonstrated 12% savings in breast, lung, colon cancer, net savings to Aetna of > $3500/case Aetna oncology pilot study with 156 physicians in 7 locations 11 % Regimen increase of generic only utilization Aetna oncology pilot study with > 200 physicians across TX 2.5 2 1.5 1 Avg. inpatient hosptial days 28 % Treatment variability reduced 0.5 0 Control group Innovent 7

We have the capabilities to equip oncologists with the tools to succeed in the new world Oncology Medical Home Solution Information Technology Care Management Support Optimal Staffing Model to provide leverage and coordinate care Financial Alignment Value based contracting and benefit steerage to drive adoption Provider Tools Patient Tools HIT Platform Clinical decision support tools to optimize care plan Automated prior-authorization to reduce administrative burden Oncology-tailored patient applications to support patients IT platform for care transitions and holistic view of patients and multi-payer usages 8

Aetna Oncology Medical Home payment for oncology care means growth instead of shortfall Growth Current Fee for Service Model Revenue Gap (e.g., private payer and CMS induced) Future Base Model(s) Without Medical Home-like contracts Invest in New processes Changes in pre-cert model alter FTE s HIT Office workflow efficiencies Enhanced drug fee schedule S-codes for quality processes that have meaning Shared Savings on improvement from baseline outcomes Sustainable Future Performance *Ultimately, this becomes a better reset baseline for episodes and/or bundles Our goal is to create a sustainable business model designed around new sources of value that will be resilient through and post health care reform. *Diagram is illustrative and for discussion purposes only

Enabling providers to focus on the right outcomes for better results MEASUREABLE METRICS Adherence to NCCN guidelines/pathways Chemo-related hospital admissions Chemo-related ER visits Cancer patients with clinical or pathologic staging prior to 1st course of treatment. Chemotherapy patients with performance status on the day of treatment Received self-management resources/materials Stage IV patients with end-oflife care discussions Patients introduced to Advance Care Planning and facilitation RELEVANT OUTCOMES Reduced avoidable hospitalizations and total bed days Reduced avoidable ED visits Improved usage of evidence based medicine with documented compliance Efficient drug regimen usage Enhanced communication/patient education Coordination and easy patient access to care for same day visits Enhanced patient understanding of therapeutic intent of therapy and life planning capabilities TECHNOLOGY ENABLED Clinical decision support technology Standardized reporting for continuous quality improvement at the office level Oncology PCMH toolkit Tight linkages to Aetna s oncology care management program Additional revenue opportunities through payfor-value contracting and oncology PCMH arrangements 10

Oncology Medical Home (OMH) programs and vendor P4V programs work together to segment and serve oncology marketplace CDS vendor Aetna developed OMH Standard Metrics Standard Reporting CDS vendor Other OMH Individual contracts that synch with existing arrangements Community practices with market presence of a vendor and ability to use the tools Community practices who don t need a vendor (sophisticated) or can t work with one (unequipped) Individual ACO s, large Hospital based Health Systems, Cancer Specialty Hospitals There is a solution for every market segment bucket, in order to gain maximum impact

Implementation and Measurement of Adherence to Clinical Pathways is the glidepath to move providers up the value chain Vendor based programs introduce Clinical Pathways and Measure Adherence along with Quality Measures Smaller Practices work with Education Oncology programs such as NJ ION program More sophisticated Practices move from vendor based Clinical Pathways programs to Oncology Medical Homes (OMH) Create episode and bundling methodology test with OMH, as well as deployed in ACO OMH deployed in 65% of markets and ACOs by 4Q15 Vendor Oncology Programs Cardinal, New Century Health, Innovent Low Touch Some Clinical Engagement Oncology Medical Homes Bundles/ Episode Payments Provider engagement Index More Clinical Engagement OMH, ACOs, Bundles High Clinical Engagement High Touch

We re using proven logic to create innovative cancer care management programs as well FUTURE VISION for Aetna s Oncology Management Program Reaching members early, serving members throughout their treatment Aetna s Oncology Management Program: Reaching members at time of diagnosis, serving members throughout their treatment Holistic, personalized approach to care Improved treatment compliance Mitigation and control of side effects Reduction/avoidance of treatment related complications Focused education for member and caregivers Network optimization Promote use of appropriate therapies and in-network providers Steerage to best-in-class facilities Effective case management when it matters most Comprehensive needs assessment including medical, nutritional, behavioral health for member as well as caregivers Efficient and appropriate utilization of benefits Access to hospice care as needed Care and resource coordination access to community and other support group networks Connection to Aetna s Compassionate Care Program for comprehensive end-of-life needs 13

We identify and support members at the most critical point in their treatment DIAGNOSIS Oncology management through ITC/ custom care unit Traditional regional case management model NURSE OUTREACH In-patient oncology claim TREATMENT PLANNING CHEMO/SURGERY NURSE OUTREACH Administration of Primary/ secondary neoplasm Outpatient radiology/ chemo Oncology Rx (specialty RX) POST TREATMENT CARE More cancer patients captured earlier for better health and financial outcomes

Employing network design to encourage utilization to preferred providers Three tiered oncology network with greatest benefit for using preferred tier LEVEL A In-network oncologist that is using a CDS platform and/or is QOPI certified LEVEL B In-network oncologist using CDS platform and is certified OPCMH (when available) In-network oncologists Out-ofnetwork oncologists Fee for service Modified fee for service plus P4P payment plus P4P payment Member pays 10% coinsurance Fee for service Member pays 20% coinsurance Fee for service Member pays 50% coinsurance Note: coinsurance numbers are theoretical and for example only 15

Member steerage / plan benefit design will be part of the longer term Solution Delivery Benefit design Coinsurance level Tiered networks Tier three Non-participating oncologist Member pays 50% Tier two In-network oncologist Member pays 20% Tier one In-network oncologist using preferred Health Delivery System (when available) Member pays 10% Lowered premiums or only option for certain network products An important component of overall approach is to systemically study the clinical and cost outcomes of cancer care management 16

Can serve ACOs looking for oncology partners A Oncology Medical Home for Hospital / Health Systems + Oncology MH Solution: 1 Hospital contracts with Aetna to provide Medical Home solution to its network oncologists Hospital System 2 Tools enable ACO to benchmark community practices 3 ACO engages oncology practices in shared savings arrangements or episode based reimbursement Practice A Practice B 17 Practice C

Can prepare oncology practices for life in an ACO model B Enablement of oncology-specific component for ACOs Oncology MH Solution: + Text Community Oncology Practice Text Hospital ACO Text Oncology Practice Payor Text Primary Care Practice 1 Aetna contracts with community 2 Aetna leverages ACS to facilitate oncology practices to become relationships between enabled medical homes oncology practices and ACOs 18

Accountable Care Oncology PCMH 3 capabilities determine long-term success Execution of these elements will bring success to triple aim goals of cost efficiency, clinical quality improvement, pt. satisfaction Clinical Decision Support Software to inform oncologist on combination of drugs used and the sequencing of how they are given Appropriateness of when to begin treatment and when to discontinue treatment A new line of therapy is generally used when a pathway did not meet clinical outcomes or the cancer progresses Care Management Support Patient education on sideeffect management during active treatment Emergency Plan allows for reduction in inpatient hospitalization and ED visit resource use Strong network steerage arm to navigate members through an integrated delivery system of care; lab, radiology, XRT EOL and Palliative Care Facilitated by physicians using Clinical Decision Support and nursing/sw Care Management Support Bolstered by Social Networking tools Understanding Hospice network and forming partnerships with oncology practices will be critical 19

Other aspects of Aetna s approach to cancer care Programs launched or in development 2013 2014 2015 2016 Value Based Contracting, using Clinical Decision Support Vendors Oncology Medical Home s Oncology Care Management Radiation Oncology vendor contracting Cancer Specialty Hospital contracting Specialty Rx Split Fill program Genomics testing partnership(s) Episode Payments 20

Let s have a collaborative approach by all stakeholders, to prevent our already fragile system from tearing itself into pieces 21